newsfilter
← Latest News
Business Wire·

Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update

Two Phase 3 Registrational Clinical Trials Fully Enrolled for CTP-543 for the Treatment of Alopecia Areata CTP-543 THRIVE-AA1 Phase 3 Trial Topline Data Expected Second Quarter of 2022 CTP-543 THRIVE-AA2 Phase 3 Trial Topline Data Expected Third Q